Corneal delivery of moxifloxacin and dexamethasone combination using drug-eluting mucoadhesive contact lens to treat ocular infections
- 1 December 2020
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 591, 120023
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India
- Newton Fund
This publication has 34 references indexed in Scilit:
- A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular deliveryEuropean Journal of Pharmaceutics and Biopharmaceutics, 2010
- Why is Chitosan Mucoadhesive?Biomacromolecules, 2008
- Solubility of Antibiotics in Different Solvents. 1. Hydrochloride Forms of Tetracycline, Moxifloxacin, and CiprofloxacinIndustrial & Engineering Chemistry Research, 2006
- Ocular drug deliveryExpert Opinion on Drug Delivery, 2006
- Comparison of Corneal Thickness After the Instillation of Topical AnestheticsCornea, 2006
- Protonation equilibrium and lipophilicity of moxifloxacinJournal of Pharmaceutical and Biomedical Analysis, 2005
- Activity of and Resistance to Moxifloxacin in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2003
- Penetration into the Anterior Chamber Via the Conjunctival/Scleral PathwayJournal of Ocular Pharmacology and Therapeutics, 1997
- Topical Ocular Drug Delivery: Recent Developments and Future ChallengesJournal of Ocular Pharmacology and Therapeutics, 1986
- Bioadhesive Polymers as Platforms for Oral Controlled Drug Delivery II: Synthesis and Evaluation of Some Swelling, Water-Insoluble Bioadhesive PolymersJournal of Pharmaceutical Sciences, 1985